Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

Thumbnail

FDA approves first contrast agent for enhanced ultrasonography of the liver

Bracco Diagnostics announced today that its Lumason ultrasound contrast agent has received FDA approval for use in enhanced liver ultrasound in both adult and pediatric patients.

Engineering educators, students push to make medical imaging as good as it can get

If the work of engineering professors and students in Marquette University’s Medical Imaging Systems Lab is any indication, the future of medical imaging looks to be nothing short of brilliant. 

Abdomen-only imaging may be best option for pregnant trauma patients

Forgoing CT scanning of the pelvis in favor of abdomen-only imaging for pregnant trauma patients is effective at reducing fetal radiation exposure, according to study results published online in the American Journal of Roentgenology.

Study: Diabetes treatments linked to reductions in mammographic breast density

Researchers have discovered that common types of treatment for diabetes can decrease mammographic breast density—a significant indicator of increased breast cancer risk—while female patients who receive insulin injections may have increased density levels, according to a study recently presented at the European Breast Cancer Conference in Amsterdam.

Thumbnail

Can advanced imaging limit overdiagnosis of breast cancer?

Determining how best to limit breast cancer overdiagnosis and overtreatment is not only an important and necessary goal, it’s also an adventure in medical science, according to a recent article published online March 23 in Academic Radiology.

Carestream submits OnSight 3D Extremity System for FDA clearance

Carestream Health has announced the filing of a 510(k) application with the FDA for clearance of its OnSight 3D Extremity System, according to a company press release.

Double reporting works well, may cost less than other corrective strategies

Computer-aided detection, structured reporting templates and various education strategies all can be effective as correctors of perceptual errors by radiologists. Meanwhile, double reporting represents a validated and arguably simpler solution than any of those approaches—and it may be more cost-effective too. 

Thumbnail

Carestream Submits Application for FDA 510(k) Clearance For Its OnSight 3D Extremity System

ROCHESTER, N.Y.--(BUSINESS WIRE)--Carestream Health has filed a 510(k) application with the FDA for clearance of itsCARESTREAM OnSight 3D Extremity System that uses cone beam CT (CBCT) technology to capture weight-bearing and other types of patient extremity images. This affordable system is designed to offer high-quality, low-dose 3D imaging for use by orthopaedic and sports medicine practices, hospitals, imaging centers, urgent care facilities and other healthcare providers.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.